Cited by 337Drug Transport and Resistance MechanismsPharmacogenetics and Drug MetabolismProtein Interaction Studies and Fluorescence Analysis

The DOI matches its Crossref record; 199 of the 199 references it cites were found in a registry or an index.

EVALUATION OF DRUG-DRUG INTERACTION IN THE HEPATOBILIARY AND RENAL TRANSPORT OF DRUGS

Shitara, Yoshihisa, Sato, Hitoshi, Sugiyama, Yuichi·2005·Annual Review of Pharmacology and Toxicology

DOI 10.1146/annurev.pharmtox.44.101802.121444

Open this paper in CoChat — free account

Abstract

Recent studies have revealed the import role played by transporters in the renal and hepatobiliary excretion of many drugs. These transporters exhibit a broad substrate specificity with a degree of overlap, suggesting the possibility of transporter-mediated drug-drug interactions with other substrates. This review is an overview of the roles of transporters and the possibility of transporter-mediated drug-drug interactions. Among the large number of transporters, we compare the Ki values of inhibitors for organic anion transporting polypeptides (OATPs) and organic anion transporters (OATs) and their therapeutic unbound concentrations. Among them, cephalosporins and probenecid have the potential to produce clinically relevant OAT-mediated drug-drug interactions, whereas cyclosporin A and rifampicin may trigger OATP-mediated ones. These drugs have been reported to cause drug-drug interactions in vivo with OATs or OATP substrates, suggesting the possibility of transporter-mediated drug-drug interactions. To avoid adverse consequences of such transporter-mediated drug-drug interactions, we need to be more aware of the role played by drug transporters as well as those caused by drug metabolizing enzymes.

Integrity signals

Registry

Crossref · 10.1146/annurev.pharmtox.44.101802.121444

Cites

199 of 199 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T. A., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,372
Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues.
Maliepaard, M., Scheffer, G. L., Faneyte, I. F., van Gastelen, M. A., Pijnenborg, A. C. L. M., Schinkel, A. H., van de Vijver, M. J., Scheper, R. J., & Schellens, J. H. M. (2001) · PubMed · Cited by 1,130
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
Schinkel, A. H., Mayer, U., Wagenaar, E., Mol, C. A. A. M., van Deemter, L., Smit, J. J. M., van der Valk, M. A., Voordouw, A. C., Spits, H., van Tellingen, O., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4028 · Cited by 937
Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.
Miyake, K., Mickley, L. A., Litman, T., Zhan, Z., Robey, R. W., Cristensen, B., Brangi, M., Greenberger, L., Dean, M. C., Fojo, T., et al. (1999) · PubMed · Cited by 819
Congenital Jaundice in Rats with a Mutation in a Multidrug Resistance-Associated Protein Gene
Paulusma, C. C., Bosma, P. J., Zaman, G. J. R., Bakker, C., Otter, M. Y., Scheffer, G. L., Scheper, R. J., Borst, P., & Elferink, R. P. J. O. (1996) · Science · doi:10.1126/science.271.5252.1126 · Cited by 817
A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance.
Allikmets, R., Schriml, L. M., Hutchinson, A. A., Romano-Spica, V., & Dean, M. C. (1998) · PubMed · Cited by 798
Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance
Pang, K. S., & Rowland, M. (1977) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059688 · Cited by 797
Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance
König, J., Nies, A. T., Cui, Y., Leier, I., & KEPPLER, D. O. R. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00169-8 · Cited by 786
Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver
Kullak-Ublick, G. A., Ismair, M. G., Stieger, B., Landmann, L., Huber, R., Pizzagalli, F., Fattinger, K. E., Meier, P. J., & Hagenbuch, B. (2001) · Gastroenterology · doi:10.1053/gast.2001.21176 · Cited by 718
Molecular and Functional Identification of Sodium Ion-dependent, High Affinity Human Carnitine Transporter OCTN2
Tamai, I., Ohashi, R., Nezu, J., Yabuuchi, H., Oku, A., Shimane, M., Sai, Y., & Tsuji, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20378 · Cited by 696

Show all 199 references

Research works printed but not linked: 52

Pang KS, 1978, J. Pharmacol. Exp. Ther., 207, 178
Lecureur V, 2000, Mol. Pharmacol., 57, 24
Yamazaki M, 2001, J. Pharmacol. Exp. Ther., 296, 723
Walle UK, 1998, Drug Metab. Dispos., 26, 343
Tanigawara Y, 1992, J. Pharmacol. Exp. Ther., 263, 840
Zhang L, 1998, J. Pharmacol. Exp. Ther., 286, 354
Yabuuchi H, 1999, J. Pharmacol. Exp. Ther., 289, 768
Wu X, 1999, J. Pharmacol. Exp. Ther., 290, 1482
Ohashi R, 1999, J. Pharmacol. Exp. Ther., 291, 778
Nakai D, 2001, J. Pharmacol. Exp. Ther., 297, 861
Ishizuka H, 1998, J. Pharmacol. Exp. Ther., 287, 37
Hosokawa S, 1992, Lab. Animal Sci., 42, 27
Muller M, 1997, Am. J. Physiol., 272, G1285
10.1016/0304-4157(95)00006-D · DOI
Taniguchi K, Cancer Res., 56, 4124
Kuwano M, 1999, Anticancer Drug Des., 14, 123
Niinuma K, 1999, Am. J. Physiol, 276, G1153
Cui Y, 1999, Mol. Pharmacol., 55, 929
Niinuma K, 1999, Am. J. Physiol, 276, G1153
Hooijberg JH, 1999, Cancer Res., 59, 2532
Zeng H, 2000, Cancer Res., 60, 4779
Allikmets R, 1998, Cancer Res., 58, 5337
Miyake K, 1999, Cancer Res., 59, 8
Maliepaard M, 2001, Cancer Res., 61, 3458
Akhteruzzaman S, 1999, J. Pharmacol. Exp. Ther., 290, 1107
Madan A, 1999, Drug Metab. Dispos., 27, 327
Kouzuki H, 1998, J. Pharmacol. Exp. Ther., 286, 1043
Kouzuki H, 1999, J. Pharmacol. Exp. Ther, 288, 627
Ito K, 1998, Pharmacol. Rev., 50, 387
Ueda K, 2001, J. Pharmacol. Exp. Ther., 297, 1036
Masuda S, 1997, J. Pharmacol. Exp. Ther., 283, 1039
Masuda S, 1999, Mol. Pharmacol., 55, 743
Takeuchi A, 2001, J. Pharmacol. Exp. Ther., 299, 261
Chu XY, 1997, J. Pharmacol. Exp. Ther., 281, 304
Gupta E, 1994, Cancer Res., 54, 3723
Regazzi MB, 1993, Transplant. Proc., 25, 2732
Hasunuma T, 2003, J. Clin. Ther. Med., 19, 381
10.1345/aph.1A116 · DOI
Mueck W, 2001, AAPS PharmSci., 3, 3566
Sallustio BC, 1996, Drug Metab. Dispos., 24, 984
Sabordo L, 1998, J. Pharmacol. Exp. Ther., 288, 414
Sabordo L, 2000, J. Pharmacol. Exp. Ther., 295, 44
Olinga P, 1998, J. Pharmacol. Exp. Ther., 285, 506
Marino EL, 1981, Int. J. Clin. Pharmacol. Ther. Toxicol., 19, 506
Kremer JM, 1995, J. Rheumatol., 22, 2072
Apiwattanakul N, 1999, Mol. Pharmacol., 55, 847
Morita N, 2001, J. Pharmacol. Exp. Ther., 298, 1179
Jariyawat S, 1999, J. Pharmacol. Exp. Ther, 290, 672
Uwai Y, 2000, J. Pharmacol. Exp. Ther., 295, 261
Cvetkovic M, 1999, Drug Metab. Dispos., 27, 866
Bossuyt X, 1996, J. Pharmacol. Exp. Ther., 276, 891–96
Sugiyama D, 2001, J. Pharmacol. Exp. Ther., 298, 316–22

Sorted by citations

Items 101–200 of 337

Prediction of human pharmacokinetics—biliary and intestinal clearance and enterohepatic circulation
Fagerholm, U. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.5.0001 · Cited by 55
Vitamin E–drug interactions: molecular basis and clinical relevance
Podszun, M. C., & Frank, J. (2014) · Nutrition Research Reviews · doi:10.1017/s0954422414000146 · Cited by 55
Positron Emission Tomography Studies Using (15R)-16-m-[11C]tolyl-17,18,19,20-tetranorisocarbacyclin Methyl Ester for the Evaluation of Hepatobiliary Transport
Takashima, T., Nagata, H., Nakae, T., Cui, Y., Wada, Y., Kitamura, S., Doi, H., Suzuki, M., Maeda, K., Kusuhara, H., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.170092 · Cited by 52
Self-citation
A Clinical Quantitative Evaluation of Hepatobiliary Transport of [11C]Dehydropravastatin in Humans Using Positron Emission Tomography
Kaneko, K., Tanaka, M., Ishii, A., Katayama, Y., Nakaoka, T., Irie, S., Kawahata, H., Yamanaga, T., Wada, Y., Miyake, T., et al. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.080408 · Cited by 52
Self-citation
Kolaviron Diminishes Diclofenac-Induced Liver and Kidney Toxicity in Wistar Rats Via Suppressing Inflammatory Events, Upregulating Antioxidant Defenses, and Improving Hematological Indices
Alabi, Q. K., & Akomolafe, R. O. (2020) · Dose-Response · doi:10.1177/1559325819899256 · Cited by 55
The Drug of Abuse γ-Hydroxybutyrate Is a Substrate for Sodium-Coupled Monocarboxylate Transporter (SMCT) 1 (SLC5A8): Characterization of SMCT-Mediated Uptake and Inhibition
Cui, D., & Morris, M. E. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.027169 · Cited by 52
Assessment of gadoxetate DCE‐MRI as a biomarker of hepatobiliary transporter inhibition
Ulloa, J. L., Stahl, S. H., Yates, J. W. T., Woodhouse, N., Kenna, J. G., Jones, H. B., Waterton, J. C., & Hockings, P. D. (2013) · NMR in Biomedicine · doi:10.1002/nbm.2946 · Cited by 52
Population Pharmacokinetics of Oseltamivir When Coadministered With Probenecid
Rayner, C. R., Chanu, P., Gieschke, R., Boak, L. M., & Jonsson, E. N. (2008) · The Journal of Clinical Pharmacology · doi:10.1177/0091270008320317 · Cited by 51
Is the Monkey an Appropriate Animal Model to Examine Drug-Drug Interactions Involving Renal Clearance? Effect of Probenecid on the Renal Elimination of H2 Receptor Antagonists
Tahara, H., Kusuhara, H., Chida, M., Fuse, E., & Sugiyama, Y. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.094052 · Cited by 51
Self-citation
Human clearance prediction: shifting the paradigm
Lavé, T., Chapman, K. L., Goldsmith, P., & Rowland, M. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903099649 · Cited by 51
In Vitro–In Vivo Extrapolation Method to Predict Human Renal Clearance of Drugs
Kunze, A., Huwyler, J., Poller, B., Gutmann, H., & Camenisch, G. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23851 · Cited by 48
Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecid
Landersdorfer, C. B., Kirkpatrick, C. M. J., Kinzig, M., Bulitta, J. B., Holzgrabe, U., Jaehde, U., Reiter, A., Naber, K. G., Rodamer, M., & Sörgel, F. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03564.x · Cited by 48
Identification of Amino Acids Essential for Estrone-3-Sulfate Transport within Transmembrane Domain 2 of Organic Anion Transporting Polypeptide 1B1
Li, N., Hong, W., Huang, H., Hanping, L., Lin, G., & Hong, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036647 · Cited by 47
Uptake and Efflux Transporters for Conjugates in Human Hepatocytes
KEPPLER, D. O. R. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)00029-7 · Cited by 47
Evaluation and Quantitative Prediction of Renal Transporter‐Mediated Drug‐Drug Interactions
Feng, B., & Varma, M. V. S. (2016) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.702 · Cited by 46
Prediction of the Effects of Genetic Polymorphism on the Pharmacokinetics of CYP2C9 Substrates from In Vitro Data
Kusama, M., Maeda, K., Chiba, K., Aoyama, A., & Sugiyama, Y. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9781-2 · Cited by 44
Self-citation
Transporter biology in drug approval: Regulatory aspects
Maeda, K., & Sugiyama, Y. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.10.012 · Cited by 46
Self-citation
Polymorphisms and Linkage Disequilibrium of the OATP8 (OATP1B3) Gene in Japanese Subjects
Tsujimoto, M., Hirata, S., Dan, Y., Ohtani, H., & Sawada, Y. (2006) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.21.165 · Cited by 44
Interaction of innovative small molecule drugs used for cancer therapy with drug transporters
Mandery, K., Glaeser, H., & Fromm, M. F. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01618.x · Cited by 42
Regulation of drug transporters by PDZ adaptor proteins and nuclear receptors
Kato, Y., Watanabe, C., & Tsuji, A. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.11.006 · Cited by 41
The Role of Permeability in Drug ADME/PK, Interactions and Toxicity—Presentation of a Permeability-Based Classification System (PCS) for Prediction of ADME/PK in Humans
Fagerholm, U. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9397-y · Cited by 41
Interaction of Digitalis-Like Compounds with Liver Uptake Transporters NTCP, OATP1B1, and OATP1B3
Gozalpour, E., Greupink, R., Wortelboer, H. M., Bilos, A., Schreurs, M., Rüssel, F. G. M., & Koenderink, J. B. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400699p · Cited by 41
Drug Transporter Expression and Activity in Human Hepatoma HuH-7 Cells
Jouan, E., Vée, M. L., Denizot, C., Parmentier, Y., & Fardel, O. (2016) · Pharmaceutics · doi:10.3390/pharmaceutics9010003 · Cited by 42
Local Kinetics and Dynamics of Xenobiotics
Pelkonen, O., Kapitulnik, J., Gundert-Remy, U., Boobis, A., & Stockis, A. (2008) · Critical Reviews in Toxicology · doi:10.1080/10408440802194931 · Cited by 39
The short-chain fatty acid butyrate is a substrate of breast cancer resistance protein
Gonçalves, P., Gregório, I., & Martel, F. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00146.2011 · Cited by 39
Impact of the Pharmaceutical Sciences on Health Care: A Reflection over the Past 50 Years
Rowland, M., Noe, C. R., Smith, D. A., Tucker, G. T., Crommelin, D. J. A., Peck, C. C., Rocci, M. L., Besançon, L., & Shah, V. P. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23295 · Cited by 40
Pharmacogenetics of Drug Transporters in the Enterohepatic Circulation
Stieger, B., & Meier, P. J. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.53 · Cited by 40
Inhibition of flucloxacillin tubular renal secretion by piperacillin
Landersdorfer, C. B., Kirkpatrick, C. M. J., Kinzig, M., Bulitta, J. B., Holzgrabe, U., & Sörgel, F. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03266.x · Cited by 37
Druggability: selecting optimized drug candidates
Sugiyama, Y. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03675-5 · Cited by 37
Self-citation
Efficient sequential synthesis of PET Probes of the COX-2 inhibitor [11C]celecoxib and its major metabolite [11C]SC-62807 and in vivo PET evaluation
Takashima‐Hirano, M., Takashima, T., Katayama, Y., Wada, Y., Sugiyama, Y., Watanabe, Y., Doi, H., & Suzuki, M. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.03.020 · Cited by 36
Self-citation
Towards longitudinal mapping of extracellular pH in gliomas
Huang, Y., Coman, D., Hermán, P., Rao, J. U., Maritim, S., & Hyder, F. (2016) · NMR in Biomedicine · doi:10.1002/nbm.3578 · Cited by 36
Interaction of sirolimus and everolimus with hepatic and intestinal organic anion-transporting polypeptide transporters
Picard, N., Levoir, L., Lamoureux, F., Yee, S. W., Giacomini, K. M., & Marquet, P. (2011) · Xenobiotica · doi:10.3109/00498254.2011.573882 · Cited by 36
Characterization of Hepatobiliary Transport Systems of a Novel α4β1/α4β7 Dual Antagonist, TR-14035
Tsuda-Tsukimoto, M., Maeda, T., Iwanaga, T., Kume, T., & Tamai, I. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9102-6 · Cited by 36
Involvement of Rat and Human Organic Anion Transporter 3 in the Renal Tubular Secretion of Topotecan [(S)-9-Dimethylaminomethyl-10-hydroxy-camptothecin hydrochloride]
Matsumoto, S., Yoshida, K., Ishiguro, N., Maeda, T., & Tamai, I. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.123323 · Cited by 36
Impact of transporter-mediated drug absorption, distribution, elimination and drug interactions in antimicrobial chemotherapy
Tsuji, A. (2006) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-006-0478-3 · Cited by 35
Intestinal transporters for endogenic and pharmaceutical organic anions: the challenges of deriving in-vitro kinetic parameters for the prediction of clinically relevant drug–drug interactions
Grandvuinet, A. S., Vestergaard, H. T., Rapin, N., & Steffansen, B. (2012) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2012.01505.x · Cited by 34
Prediction of Pharmacokinetic Profile of Valsartan in Humans Based onin vitroUptake‐Transport Data
Poirier, A., Cascais, A., Funk, C., & Lavé, T. (2009) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900116 · Cited by 34
Genetics or environment in drug transport: the case of organic anion transporting polypeptides and adverse drug reactions
Clarke, J., & Cherrington, N. J. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.656087 · Cited by 34
In Vivo Visualization and Quantification of (Disturbed) Oatp-Mediated Hepatic Uptake and Mrp2-Mediated Biliary Excretion of 99mTc-Mebrofenin in Mice
Neyt, S., Huisman, M. T., Vanhove, C., Man, H. D., Vliegen, M., Moerman, L., Dumolyn, C., Mannens, G., & Vos, F. D. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.108233 · Cited by 34
Expression and function of renal and hepatic organic anion transporters in extrahepatic cholestasis
Brandoni, A. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i44.6387 · Cited by 33
Membrane Carriers and Transporters in Kidney Physiology and Disease
Droździk, M., Droździk, M., & Oswald, S. (2021) · Biomedicines · doi:10.3390/biomedicines9040426 · Cited by 32
Molecular properties associated with transporter-mediated drug disposition
Varma, M. V. S., Lai, Y., & El‐Kattan, A. F. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.014 · Cited by 31
Inhibitory Effect of Caffeic Acid on Human Organic Anion Transporters hOAT1 and hOAT3: A Novel Candidate for Food–Drug Interaction
Uwai, Y., Ozeki, Y., Isaka, T., Honjo, H., & Iwamoto, K. (2011) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-11-rg-020 · Cited by 31
Onco-cardiology: Drug-drug interactions of antineoplastic and cardiovascular drugs
Akbulut, İ. M., & Ürün, Y. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.102822 · Cited by 31
Enzyme-Transporter Interplay in the Formation and Clearance of Abundant Metabolites of Faldaprevir Found in Excreta but not in Circulation
Li, Y., Zhou, J., Ramsden, D., Taub, M., O'Brien, D., Xu, J., Busacca, C. A., Gonnella, N., & Tweedie, D. (2014) · Drug Metabolism And Disposition · doi:10.1124/dmd.113.055863 · Cited by 31
Characterization of 22 Antituberculosis Drugs for Inhibitory Interaction Potential on Organic Anionic Transporter Polypeptide (OATP)-Mediated Uptake
Parvez, M. M., Jung, J. A., Shin, H. J., Kim, D., & Shin, J. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02765-15 · Cited by 30
Handbook of Preformulation: Chemical, Biological, and Botanical Drugs
Niazi, S. K. (2006) · Cited by 29
The Increased Cellular Uptake and Biliary Excretion of Curcumin by Quercetin: A Possible Role of Albumin Binding Interaction
Kim, H. G., Lee, J. H., Lee, S. J., Oh, J., Shin, E.-J., Jang, Y. P., & Lee, Y. J. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.044123 · Cited by 29
Drug Excretion
Taft, D. R. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-369521-5.00009-9 · Cited by 29
How do neurons in sensory ganglia communicate with satellite glial cells?
Feldman‐Goriachnik, R., & Menachem Hanani, A. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147384 · Cited by 28
Organic Cation Transporters in the Lung—Current and Emerging (Patho)Physiological and Pharmacological Concepts
Selo, M. A., Sake, J. A., Ehrhardt, C., & Salomon, J. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239168 · Cited by 29
Drug–drug interaction with statins
Corsini, A., & Bellosta, S. (2008) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.1.1.105 · Cited by 28
Functional Consequences of Active Hepatic Uptake on Cytochrome P450 Inhibition in Rat and Human Hepatocytes
Grime, K., Webborn, P. J. H., & Riley, R. J. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.021055 · Cited by 27
Carrier-Mediated Uptake of 1-(2-Methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d ]imidazolium Bromide (YM155 Monobromide), a Novel Small-Molecule Survivin Suppressant, into Human Solid Tumor and Lymphoma Cells
Minematsu, T., Iwai, M., Sugimoto, K., Shirai, N., Nakahara, T., Usui, T., & Kamimura, H. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.025254 · Cited by 27
Hepatic Uptake in the Dog: Comparison of Uptake in Hepatocytes and Human Embryonic Kidney Cells Expressing Dog Organic Anion-Transporting Polypeptide 1B4
Wilby, A. J., Maeda, K., Courtney, P. F., Debori, Y., Webborn, P. J. H., Kitamura, Y., Kusuhara, H., Riley, R. J., & Sugiyama, Y. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.041814 · Cited by 27
Self-citation
Noninvasive Evaluation of Cellular Proliferative Activity in Brain Neurogenic Regions in Rats under Depression and Treatment by Enhanced [18F]FLT-PET Imaging
Tamura, Y., Takahashi, K., Takata, K., Eguchi, A., Yamato, M., Kume, S., Nakano, M., Watanabe, Y., & Kataoka, Y. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0220-16.2016 · Cited by 29
Clinical Hepatotoxicity. Regulation and Treatment with Inducers of Transport and Cofactors
Marschall, H., Wagner, M., Zollner, G., & Trauner, M. (2007) · Molecular Pharmaceutics · doi:10.1021/mp060133c · Cited by 27
Establishment of human induced pluripotent stem cell-derived hepatobiliary organoid with bile duct for pharmaceutical research use
Wang, L., Koui, Y., Kanegae, K., Kido, T., Tamura-Nakano, M., Yabe, S., Tai, K., Nakajima, Y., Kusuhara, H., Sakai, Y., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122621 · Cited by 25
A 20-Year Research Overview: Quantitative Prediction of Hepatic Clearance Using the In Vitro-In Vivo Extrapolation Approach Based on Physiologically Based Pharmacokinetic Modeling and Extended Clearance Concept
Sugiyama, Y., & Aoki, Y. (2023) · Drug Metabolism and Disposition · doi:10.1124/dmd.123.001344 · Cited by 25
Self-citation
Use ofin vitrotransporter assays to understand hepatic and renal disposition of new drug candidates
Sahi, J. (2005) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.1.3.409 · Cited by 25
Inhibition of SLC drug transporter activities by environmental bisphenols
Bruyère, A., Hubert, C., Vée, M. L., Chedik, L., Sayyed, K., Stieger, B., Denizot, C., Parmentier, Y., & Fardel, O. (2016) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.12.009 · Cited by 25
Evaluation of possible drug–drug interaction between gadoxetic acid and erythromycin as an inhibitor of organic anion transporting peptides (OATP)
Huppertz, A., Breuer, J., Fels, L. M., Schultze‐Mosgau, M., Sutter, G., Klein, S., Frericks, B. B., Hamm, B., & Wagner, M. (2011) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22458 · Cited by 24
First-principle, structure-based prediction of hepatic metabolic clearance values in human
Li, H., Sun, J., Sui, X., Liu, J., Yan, Z., Liu, X., Sun, Y. H., & He, Z. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.07.027 · Cited by 24
A kinetic fluorescence assay reveals unusual features of Ca++ uptake in Plasmodium falciparum-infected erythrocytes
Zipprer, E. M., Neggers, M., Kushwaha, A. K., Rayavara, K., & Desai, S. A. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-184 · Cited by 24
QSAR analysis of the effects of OATP1B1 transporter by structurally diverse natural products using a particle swarm optimization-combined multiple linear regression approach
Cao, D., Shao, L., Fan, L., & Liang, Y. (2013) · Chemometrics and Intelligent Laboratory Systems · doi:10.1016/j.chemolab.2013.10.011 · Cited by 23
Protein expression of kidney and liver bilitranslocase in rats exposed to mercuric chloride—A potential tissular biomarker of toxicity
Trebucobich, M. S., Hazelhoff, M. H., Chevalier, A. A., Passamonti, S., Brandoni, A., & Torres, A. M. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.11.022 · Cited by 23
Metabolism and Renal Elimination of Gaboxadol in Humans: Role of UDP-Glucuronosyltransferases and Transporters
Chu, X., Liang, Y., Cai, X., Cuevas‐Licea, K. G., Rippley, R. K., Kassahun, K., Shou, M., Braun, M. P., Doss, G. A., Anari, M. R., et al. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9799-5 · Cited by 23
Causes and Consequences of Variability in Drug Transporter Activity in Pediatric Drug Therapy
Rodieux, F., Gotta, V., Pfister, M., & van den Anker, J. N. (2016) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.721 · Cited by 23
Physiologically Based Pharmacokinetic Modeling in Neonates: Current Status and Future Perspectives
Zhang, W., Zhang, Q., Cao, Z., Zheng, L., & Hu, W. M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15122765 · Cited by 22
Drugs interacting with organic anion transporter-1 affect uptake of Tc-99m-mercaptoacetyl-triglycine (MAG3) in the human kidney: Therapeutic drug interaction in Tc-99m-MAG3 diagnosis of renal function and possible application of Tc-99m-MAG3 for drug development
Takahara, N., Saga, T., Inubushi, M., Kusuhara, H., Seki, C., Ito, S., Oyama, N., Yokoyama, O., Sugiyama, Y., & Fujibayashi, Y. (2013) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2013.03.006 · Cited by 22
Self-citation
Transport mechanisms of hepatic uptake and bile excretion in clinical hepatobiliary scintigraphy with 99mTc-N-pyridoxyl-5-methyltryptophan
Kobayashi, M., Nakanishi, T., Nishi, K., Higaki, Y., Okudaira, H., Ono, M., Tsujiuchi, T., Mizutani, A., Nishii, R., Tamai, I., et al. (2014) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2014.01.004 · Cited by 22
Effect of cyclosporin A on the biliary excretion of cholephilic compounds in rats
Akashi, M., TANAKA, A., & TAKIKAWA, H. (2006) · Hepatology Research · doi:10.1016/j.hepres.2005.08.013 · Cited by 22
Assessment of the renal toxicity of novel anti-inflammatory compounds using cynomolgus monkey and human kidney cells
Cai, H., Agrawal, A. K., Putt, D. A., Hashim, M. F., Reddy, A., Brodfuehrer, J., Surendran, N., & Lash, L. H. (2009) · Toxicology · doi:10.1016/j.tox.2009.01.006 · Cited by 21
Change of drug excretory pathway by CCl4-induced liver dysfunction in rat
Okumura, H., Katoh, M., Minami, K., Nakajima, M., & Yokoi, T. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.04.025 · Cited by 21
Identification and characterization of a potent and selective inhibitor of human urate transporter 1
Wu, T., Chen, J., Dong, S., Li, H., Cao, Y., Tian, Y., Fu, W., Zhou, P., Xi, B., & Pang, J. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.04.022 · Cited by 20
Factors affecting the pharmacokinetic profile of MS-275, a novel histone deacetylase inhibitor, in patients with cancer
Acharya, M. R., Karp, J. E., Sausville, E. A., Hwang, K., Ryan, Q. C., Gojo, I., Venitz, J., Figg, W. D., & Sparreboom, A. (2006) · Investigational New Drugs · doi:10.1007/s10637-005-5707-6 · Cited by 20
Species-Specific Interaction of HIV Protease Inhibitors With Accumulation of Cholyl-Glycylamido-Fluorescein (CGamF) in Sandwich-Cultured Hepatocytes
Ye, Z., van Pelt, J. F., Camus, S., Snoeys, J., Augustijns, P., & Annaert, P. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22018 · Cited by 20
Carvacrol exerts nephroprotective effect in rat model of diclofenac-induced renal injury through regulation of oxidative stress and suppression of inflammatory response
Nouri, A., Shirian, F. I., Fanaei, V., Dastan, M., Abolfathi, M., Moradi, A., Khaledi, M., & Jahangiri, H. M. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e08358 · Cited by 19
An Introduction to Drug–Nutrient Interactions
Boullata, J. I. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-362-6_1 · Cited by 19
Towards human ex vivo organ perfusion models to elucidate drug pharmacokinetics in health and disease
Stevens, L. J., Donkers, J. M., Dubbeld, J., Vaes, W. H. J., Knibbe, C. A. J., Alwayn, I. P. J., & van de Steeg, E. (2020) · Drug Metabolism Reviews · doi:10.1080/03602532.2020.1772280 · Cited by 19
Tratamento das dislipidemias: como e quando indicar a combinação de medicamentos hipolipemiantes
Schulz, I. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000200021 · Cited by 19
Resolving the Distribution–Metabolism Interplay of Eight OATP Substrates in the Standard Clearance Assay with Suspended Human Cryopreserved Hepatocytes
Nordell, P., Winiwarter, S., & Hilgendorf, C. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400253f · Cited by 19
Amino Acid Residues in the Putative Transmembrane Domain 11 of Human Organic Anion Transporting Polypeptide 1B1 Dictate Transporter Substrate Binding, Stability, and Trafficking
Hong, W., Wu, Z., Fang, Z., Huang, J., Huang, H., & Hong, M. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00466 · Cited by 18
A Quantitative Framework and Strategies for Management and Evaluation of Metabolic Drug-Drug Interactions in Oncology Drug Development
Venkatakrishnan, K., Pickard, M. D., & Moltke, L. L. (2010) · Clinical Pharmacokinetics · doi:10.2165/11536740-000000000-00000 · Cited by 18
Lead optimisation of pyrazoles as novel FPR1 antagonists
Morley, A., King, S. J., Roberts, B., Lever, S. R., Teobald, B. J., Fisher, A. J., Cook, T. R., Parker, B., Wenlock, M. C., Phillips, C., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.10.090 · Cited by 18
Importance of Drug Transporters in Pharmacokinetics and Drug Safety
Ward, P. (2008) · Toxicology Mechanisms and Methods · doi:10.1080/15376510701795306 · Cited by 18
Role of Organic Anion Transporters in the Pharmacokinetics of Zonampanel, an α-Amino-3-hydroxy-5-methylisoxazole-4-propionate Receptor Antagonist, in Rats
Minematsu, T., Hashimoto, T., Aoki, T., Usui, T., & Kamimura, H. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.019828 · Cited by 18
Drug Excretion
Barreto, E. F., Larson, T. R., & Koubek, E. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.99999-7 · Cited by 17
Competitive Inhibition of Renal Tubular Secretion of Gemifloxacin by Probenecid
Landersdorfer, C. B., Kirkpatrick, C. M. J., Kinzig, M., Bulitta, J. B., Holzgrabe, U., Drusano, G. L., & Sörgel, F. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01200-08 · Cited by 17
Synthesis, in vitro and in vivo small-animal SPECT evaluation of novel technetium labeled bile acid analogues to study (altered) hepatic transporter function
Neyt, S., Vliegen, M., Verreet, B., Lombaerde, S. D., Braeckman, K., Vanhove, C., Huisman, M. T., Dumolyn, C., Kersemans, K., Hulpia, F., et al. (2016) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2016.07.001 · Cited by 17
Novel cationic and neutral glycocholic acid and polyamine conjugates able to inhibit transporters involved in hepatic and intestinal bile acid uptake
Vicens, M., Medarde, M., Macı́as, R. I. R., Larena, M. G., Villafaina, A., Serrano, M. A., & Marı́n, J. J. G. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.01.027 · Cited by 17
Drug transporter expression profiling in a three-dimensional kidney proximal tubule in vitro nephrotoxicity model
Diekjürgen, D., & Grainger, D. W. (2018) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-018-2150-z · Cited by 16
Effect of Korean Red Ginseng extracts on drug-drug interactions
Kim, S.-J., Choi, S., Kim, M. S., Park, C.-M., Kim, G., Lee, S., Kang, W., & Rhee, D. (2017) · Journal of Ginseng Research · doi:10.1016/j.jgr.2017.08.008 · Cited by 16
Potentiation of MRP2/Mrp2‐Mediated Estradiol‐17β‐Glucuronide Transport by Drugs – A Concise Review
Herédi‐Szabó, K., Jemnitz, K., Kis, E., Ioja, E., Jánossy, J., Vereczkey, L., & Krajcsi, P. (2009) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900102 · Cited by 15
Ongoing Challenges in Drug Interaction Safety: from Exposure to Pharmacogenomics
Bai, J. P. F. (2010) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.25.62 · Cited by 15
Contribution of organic anion transporting polypeptide (OATP) 1B1 and OATP1B3 to hepatic uptake of nateglinide, and the prediction of drug–drug interactions via these transporters
Takanohashi, T., Kubo, S., Arisaka, H., Shinkai, K., & Ubukata, K. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01389.x · Cited by 15
Probenecid effects on cephalexin pharmacokinetics and pharmacodynamics in healthy volunteers
Everts, R. J., Gardiner, S. J., Zhang, M., Begg, R., Chambers, S. T., Turnidge, J. D., & Begg, E. J. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.05.037 · Cited by 15
Interacciones medicamentosas. Nuevos aspectos
Morales‐Olivas, F. J., & Estañ, L. (2006) · Medicina Clínica · doi:10.1157/13091269 · Cited by 15
Cytochrome P450 Enzymes, Drug Transporters and their Role in Pharmacokinetic Drug-Drug Interactions of Xenobiotics: A Comprehensive Review
Maddi, S. (2017) · Open Journal of Chemistry · doi:10.17352/ojc.000006 · Cited by 15
The Potential Drug-Drug Interactions of Ginkgolide B Mediated by Renal Transporters
Qiu, Z., Wang, L., Dai, Y., Ren, W., Jiang, W., Chen, X., & Li, N. (2015) · Phytotherapy Research · doi:10.1002/ptr.5294 · Cited by 14

Authors: Shitara, Y., Sato, H., & Sugiyama, Y.
Affiliations: SHOWA Medical University (JP)
The University of Tokyo (JP)
ORCID: Sato, Hitoshi
Sugiyama, Yuichi
Venue: Annual Review of Pharmacology and Toxicology
Publisher: Annual Reviews
Published: 2005-09-22
Volume: 45
Issue: 1
Pages: 689-723
ISSN: 0362-1642 (ISSN-L)
1545-4304
DOI: 10.1146/annurev.pharmtox.44.101802.121444
OpenAlex: W2066382275
Cited by: 336
References: 199
Citations by year: 2026: 2 · 2025: 3 · 2024: 4 · 2023: 5 · 2022: 5 · 2021: 11 · 2020: 8 · 2019: 7 · 2018: 9 · 2017: 14 · 2016: 15 · 2015: 12 · 2014: 14 · 2013: 23 · 2012: 25
FWCI: 2.12
Type: journal article
Language: en
Open access: closed
Locations: The Annual Review of Pharmacology and Toxicology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Interaction Studies and Fluorescence Analysis
Keywords: drug-drug interactions, drug transporters, renal drug excretion, organic anion transporting polypeptides, organic anion transporters, transporter inhibitors, Ki values, substrate specificity, probenecid, cephalosporins, cyclosporine, rifampicin, drug-metabolizing enzymes
MeSH terms: Animals, Biliary Tract, Biological Transport, Drug Evaluation, Drug Interactions, Pharmaceutical Preparations, Humans, Kidney, Liver

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

EVALUATION OF DRUG-DRUG INTERACTION IN THE HEPATOBILIARY AND RENAL TRANSPORT OF DRUGS

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks